Stonepine Capital Management, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Stonepine Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$0.59 - $0.9 $394,482 - $601,753	-668,615 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$0.79 - $1.11 $1.06 Million - $1.49 Million	-1,339,391 Reduced 66.7%	668,615 $573,000
Q1 2019 May 14, 2019	BUY	$0.6 - $1.41 $1.2 Million - $2.83 Million	2,008,006 New	2,008,006 $2.19 Million

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.